Literature DB >> 1247802

Editorial: Autoantibodies in breast cancer.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247802      PMCID: PMC1638509          DOI: 10.1136/bmj.1.6004.244

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  11 in total

1.  Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis.

Authors:  J Wasserman; U Glas; H Blomgren
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

2.  Hypothalamic-pituitary-thyroid axis in breast cancer.

Authors:  I Mittra; J L Hayward
Journal:  Lancet       Date:  1974-05-11       Impact factor: 79.321

3.  Hypothalamic-pituitary-prolactin axis in breast cancer.

Authors:  I Mittra; J L Hayward; A S McNeilly
Journal:  Lancet       Date:  1974-05-11       Impact factor: 79.321

4.  Antinuclear antibodies in patients with malignancies.

Authors:  T K Burnham
Journal:  Lancet       Date:  1972-08-26       Impact factor: 79.321

5.  Malignancy associated with antinuclear antibodies.

Authors:  J O Zeromski; M K Górny; K Jarczewska
Journal:  Lancet       Date:  1972-11-11       Impact factor: 79.321

6.  Mammotropic effect of prolactin enhanced by thyroidectomy.

Authors:  I Mittra
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

7.  Reaction of human smooth muscle antibody with liver cells.

Authors:  L J Farrow; E J Holborow; W D Brighton
Journal:  Nat New Biol       Date:  1971-08-11

8.  Potency of thyroid hormone analogues in suppressing prolactin-mediated mammary growth in thyroidectomized rats.

Authors:  I Mittra
Journal:  Experientia       Date:  1975-10-15

9.  Breast cancer in patients with Hashimoto's thyroiditis.

Authors:  K Ito; N Maruchi
Journal:  Lancet       Date:  1975-12-06       Impact factor: 79.321

10.  Increase of contractile proteins in human cancer cells.

Authors:  G Gabbiani; P Trenchev; E J Holborow
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.